[국제]600,000 Israelis were vaccinated against Pfizer, and “94% prevention rate”… no difference from clinical

[국제]600,000 Israelis were vaccinated against Pfizer, and “94% prevention rate”… no difference from clinical

by

[앵커]

Pfizer-Bioentech’s analysis of the effectiveness of the COVID-19 vaccine is being conducted one after another in Israel.

This time, the results for 600,000 people who completed the second vaccination were found, and a 94% prevention rate was confirmed.

This is reporter Kim Jeong-hoe.

[기자]

Up to 94% of the Pfizer vaccine has been confirmed in Israel.

This is the result of comparing the non-vaccinated group and infection with 600,000 people who completed both the 1st and 2nd vaccinations.

The number of cases of severe development after infection also decreased by 92%.

There is no significant difference from Pfizer’s Phase 3 clinical results reported with a 95% prevention rate.

The study was conducted by Claret, Israel’s largest health agency, with encouraging results and emphasized the effectiveness of the two doses.

This is because the Pfizer vaccine elicits 52% of the preventive effects after the first vaccination and up to 95% through the second vaccination 3 weeks later.

[나흐만 아쉬 / 이스라엘 코로나19 대응 책임자 : 모두에게 아직 끝난 게 아니라고 말하고 싶습니다. 두 번째 백신을 맞아도 여전히 조심하고 신경을 써야 합니다.]

In Israel last month, a similar study was published by another health agency.

As a result of comparing 160,000 people who completed the 1st and 2nd vaccinations with those who were not inoculated, 92% prevention rate was found.

A test result of the number of virus populations in body fluids conducted by Israel’s largest corona19 testing agency was also reported, which was more than 60% lower than those in their 40s-50s with a high vaccinated rate.

[사피르 아야르 / 양로원 종사자 : 코로나19에 걸리는 것보다는 백신을 맞는 게 더 낫습니다. 모든 사람이 맞아야 합니다.]

The first cases of such large-scale surveys of vaccinationists follow because Israel has secured a large volume with Pfizer as a condition of providing real-time vaccination data.

Israel began a large-scale vaccination of the Pfizer vaccine on December 19 last year, and as of the morning of the 15th local time, about 3.9 million people out of the total population of 9.3 million completed the first dose, and about 2.35 million people completed the second dose.

This is YTN Kim Jeong-hoe.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]

.Source